Stephen A. Goldman MD, FAPM, DFAPA

Dr. Goldman is Managing Member of Stephen A. Goldman Consulting Services, L.L.C. (Morris Plains, NJ), providing pharmaceutical and medical device companies internationally with safety-related services (consulting; auditing; training) involving clinical trials, postmarketing surveillance/vigilance, signal detection/evaluation, regulatory compliance and risk management (www.sagcs.com). In more than six years at the FDA, Dr. Goldman completed a fellowship in Clinical Pharmacology and Regulatory Drug Evaluation Sciences, and became MedWatch’s first Medical Director. As such, all FDA Centers utilized him as an in-house safety/risk management and communication expert. After federal service, Dr. Goldman was Director, Pharmacoepidemiology at Knoll Pharmaceutical Company (Abbott Laboratories). Dr. Goldman is a Fellow of the Academy of Psychosomatic Medicine and Distinguished Fellow of the American Psychiatric Association.